Michael M Wormald

Human Anti-Plague Monoclonal Antibodies Protect Mice from Yersinia pestis in a Bubonic Plague Model

Jennifer L. Dankmeyer, D. Dimitrov, Zhongyu Zhu, 2010, PloS one.

Synthesis and characterization of novel isoform-selective IP6K1 inhibitors.

J. Barrow, Glen E Ernst, Huijun Wei, 2019, Bioorganic & medicinal chemistry letters.

Formyl Group Activation of a Bromopyrrole Ester in Suzuki Cross-Coupling Reactions: Application to a Formal Synthesis of Polycitone A and B and Polycitrin A.

Andrew Harrison, J. Gupton, Jon Patteson, 2014, Tetrahedron.

Identification of Small-Molecule Inhibitors of Human Inositol Hexakisphosphate Kinases by High-Throughput Screening.

M. Ferrer, J. Barrow, Xin Hu, 2021, ACS pharmacology & translational science.

Development of a PC12 Cell Based Assay for Screening Catechol-O-methyltransferase Inhibitors

J. Barrow, G. Liao, Gongliang Zhang, 2019, ACS chemical neuroscience.

Development of a PC12 cell-based assay for in vitro screening of catechol-O-methyltransferase inhibitors

J. Barrow, G. Liao, Gongliang Zhang, 2019, bioRxiv.

Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against Yersinia pestis Infection in a Bubonic Plague Model

Sarah L. Keasey, Jennifer L. Dankmeyer, P. Worsham, 2020, Antibodies.

Development of a homogenous high-throughput assay for inositol hexakisphosphate kinase 1 activity

J. Barrow, M. Kimos, Huijun Wei, 2017, PloS one.